NDVUX | VSCAX | NDVUX / VSCAX | |
Total Expense Ratio | 0.96 | 1.12 | 86% |
Annual Report Gross Expense Ratio | 0.97 | 1.12 | 87% |
Fund Existence | 14 years | 26 years | - |
Gain YTD | 0.955 | 7.741 | 12% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.87B | 7.33B | 39% |
Annual Yield % from dividends | 1.48 | 0.32 | 458% |
Returns for 1 year | 0.70 | 15.41 | 5% |
Returns for 3 years | 7.19 | 40.62 | 18% |
Returns for 5 years | 44.24 | 121.06 | 37% |
Returns for 10 years | 58.91 | 39.52 | 149% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ITRAX | 24.36 | 0.03 | +0.12% |
VY® T. Rowe Price Capital Apprec A | |||
DFSGX | 25.45 | 0.03 | +0.12% |
DF Dent Small Cap Growth Institutional | |||
NQVCX | 55.55 | -0.04 | -0.07% |
Nuveen Multi Cap Value C | |||
MVISX | 51.09 | -0.14 | -0.27% |
Patient Opportunity IS | |||
FTMSX | 26.87 | -0.12 | -0.44% |
FullerThaler Behvrl Mcr-Cp Eq Instl |